FMS

20.4401.54%
CH

Charles Hugh-Jones

Global Chief Medical Officer & Member of Management Board

Mr. Charles Hugh-Jones, M.D., FRCP, has been the Global Chief Medical Officer and Member of the Management Board at Fresenius Medical Care AG since January 01, 2026. Dr. Charles is Director of InterWell Health, LLC from March 2026. Dr. Hugh-Jones is Global Chief Medical Officer & Member of the Management Board of Fresenius Medical Care North America Holdings Limited Partnership from January 1, 2026. He is Non-Executive Director of Fresenius Medical Care Holdings, Inc. from January 1, 2026. He was CEO until May 2025 and he was a Director of Volastra Therapeutics, Inc. He is Director of eGenesis, Inc. from August 2026. He is an experienced biotech leader and a board-certified physician. Prior to joining Volastra Therapeutics, Inc., he served as the global Chief Medical Officer at Allergan PLC. Before Allergan, he worked for Pfizer Oncology as their Chief Medical Officer and had medical oversight of all late-stage drug development and commercialization activities. He began his career at Schering AG, Enzon Pharmaceuticals and Sanofi, where he held various positions of increasing responsibility. He received his bachelor’s in neuroanatomy from the University of London. Mr. Hugh-Jones holds an MD from Charing Cross and Westminster Medical School, University of London and is a Fellow of the Royal College of Physicians of the UK. He went on to complete higher specialist training in diagnostic radiology.

Positions